Lung Biopsy Systems Market Segmentation:
Procedure Type (Transbronchial, Thoracoscopic, Open Biopsy)
The open biopsy segment is estimated to hold 68% share of the global lung biopsy systems market in the coming years owing to the higher number of patients receiving it. Open lung biopsy is the most common type of biopsy that is performed to check for the sigh of diseases in the lungs. It is tolerably risk-free and generally regarded as the most reliable biopsy technique. Hospitals use general anesthesia to perform open lung biopsies, where during the entire operation, patients are asleep and don't feel any pain.
End-User (Cancer Research Centers, Specialty Clinics, Hospitals)
Lung biopsy systems market from the hospitals segment is set to garner a notable share in the near future owing to an increasing number of hospitals. This offers patients with better access to healthcare services which can result in a huge number of lung biopsies being performed. For instance, patients now have a new, minimally invasive lung biopsy option available from the hospital which offers the technology and medical know-how to retrieve lung biopsy tissue samples from the deepest parts of the lung, to improve the chances of lung disease diagnosis and treatment. Besides this, hospitals provide round-the-clock services to patients and are equipped with advanced medical equipment. Medical professionals who have expertise in lung biopsy systems are also easily available within hospital premises.
Our in-depth analysis of the global lung biopsy systems market includes the following segments:
|
Product Type |
|
|
Procedure Type |
|
|
End Use |
|
